Prof. Nam Hoon Cho

Yonsei Medical University, South Korea

Email: cho1988@yuhs.ac

Qualifications

1995  Ph.D., Yonsei University College of Medicine, Korea

Publications (Selected)

1. Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro. J Cell Sci 2010; 123:3507-14
2. Molecular portraits of intratumoral heterogeneity in human ovarian cancer. Cancer Lett 2011;307:62-71
3. Proteomic molecular portrait of interface zone in breast cancer. J Proteome Res 2010 9:5638-45
4. Laminin-332-rich tumor microenvironment for tumor invasion in the interface zone of breast cancer. Am J Pathol 2011; 178: 373-81
5. CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene, 2010; 29: 2672-80
6. Molecular Proteomics Imaging of Tumor Interfaces by Mass Spectrometry. J Proteome Res 2010; 9:1157-64
7. Detection of sexually transmitted infection and HPV in negative cytology by Multiplex-PCR. BMC Infec Ds 2010; 10: 284
8. Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance. Cancer 2011; 117:1864-73.
9. Role of p53 in antioxidant defense of HPV-positive cervical carcinoma cells following H2O2 exposure. J Cell Sci 2007; 120:2284-90
10. HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer 2007; 120:1418-25
11. Targeted RNA interference of phosphatidylinositol 3-kinase p110-beta induces apoptosis and proliferation arrest in endometrial carcinoma cells. J Pathol 2007; 212:161-9
12. Induction of Cell Apoptosis in Non-Small Cell Lung Cancer Cells by Cyclin A1 SiRNA. Cancer Science  2006; 97:1082-92
13. Comparative Proteomics of Ovarian Epithelial Tumors. J Proteome Res 2006;5: 1082-90.
14. Comparative proteomics of pulmonary tumors with neuroendocrine differentiation. J Proteome Res 2006 5:643-50
15. Methylation of p16INK4a Is a Non-Rare Event in Cervical Intraepithelial Neoplasia.  Diag Mol Pathol  2006,15:74-82
16. Elevation of cyclin B1, active cdc2, and HuR in cervical neoplasia with human papillomavirus type 18 infection. Cancer Lett 2006, 232:170-8.
17. Proteomic Analysis of Progressive Factors in Uterine Cervical Cancer. Proteomics 2005 5: 1481-93.
18. Loss of cyclin B1 followed by downregulation of cyclin A/cdk2, apoptosis and ati-proliferation in HeLa cell line. Int J Cancer 2005 116; 520-5.
19. Synchronous Coexpression of Epidermal Growth Factor Receptor and Cyclooxygenase-2 in Carcinomas of the Uterine Cervix. Clin Cancer Res 2004; 10:1366-74.
20. MMP expression profiling in recurrent stage IB lung cancer. Oncogene 2004;23:845-51
21. Expression of stem cell markers in an uterine endometrium over a lifetime. Fertil Steril 2004;81:403-7
22. Prospective evaluation of longitudinal changes in human papillomavirus genotype and phylogenetic clade associated with cervical disease progression. Gynecol Oncol. 2011; 120:284-90